Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 71205-095

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 71205-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol HCl Structural Formula (Labetalol HCl Tablets 1)

Labetalol HCl Structural Formula (Labetalol HCl Tablets 1)
Chemical structure of labetalol hydrochloride, showing the molecular arrangement of its functional groups including phenyl rings, hydroxyl groups, amide, and hydrochloride component.*
FDA Label Image

71205-095-90 (Labetalol HCl Tablets 2)

71205-095-90 (Labetalol HCl Tablets 2)
Label for Labetalol hydrochloride 100 mg film-coated tablets, prescription drug. The label shows 90 tablets per container. Tablets are described as round, beige, film-coated, debossed with "WATSON 605" on one side and scored on the other. Manufactured by Watson Pharma Private Limited, India, and packaged by Proficient Rx LP, Thousand Oaks, California. Temperature storage instructions and medication safety warning are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.